Search results for "Pulmonary Disease"

showing 10 items of 360 documents

A sense of belonging: A meta-ethnography of the experience of patients with chronic obstructive pulmonary disease receiving care through telemedicine.

2019

To synthesize the qualitative research in the literature addressing how patients with chronic obstructive pulmonary disease experience care received by telemedicine.Meta-ethnography.Twelve studies, published from 2013 - 2018, were identified by a search of relevant systematic databases in June 2017, including updated searches performed in June 2018.The studies were reviewed and critically appraised independently by three researchers. The review followed the seven steps of meta-ethnography developed by Noblit and Hare, including a line-of-argument synthesis.The synthesis revealed three second-order constructs: presence, transparency, and ambivalence. Using a line-of-argument synthesis, a mod…

medicine.medical_specialtyTelemedicinePsychological interventionPulmonary diseaseNurse–client relationshipSense of belonging03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicinemedicineHumans030212 general & internal medicineIntensive care medicineGeneral NursingAnthropology CulturalQualitative ResearchCOPD030504 nursingbusiness.industryBelongingnessmedicine.diseaseTelemedicinePatient Satisfaction0305 other medical sciencebusinessQualitative researchJournal of advanced nursingREFERENCES
researchProduct

Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis

2018

Fulvio Braido,1 Pierachille Santus,2 Angelo Guido Corsico,3 Fabiano Di Marco,4 Giovanni Melioli,5 Nicola Scichilone,6 Paolo Solidoro7 1Department of Internal Medicine, IRCCS San Martino di Genova University Hospital, Genoa, Italy; 2Department of Biomedical and Clinical Sciences, University of Milan, Division of Respiratory Diseases, “L. Sacco” University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy; 3Department of Internal Medicine and Therapeutics, Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, University of Pavia, Italy; 4Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy; 5Center for Precision Medici…

medicine.medical_specialtyValidation studyConcordance analysisbusiness.industryGeneral MedicinePrimary careInternational Journal of Chronic Obstructive Pulmonary Diseasemedicine.diseasecomputer.software_genreObstructive lung diseaseExpert system03 medical and health sciences0302 clinical medicine030228 respiratory systemSample size determinationConcomitantEmergency medicinemedicine030212 general & internal medicineMedical diagnosisbusinesscomputerInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Cardiorespiratory responses to basic aquatic exercise – A pilot study

2006

This study aimed to examine cardiorespiratory responses to six basic aquatic exercises and to compare the impact of the exercises between healthy females (H group, n=10) and females with diagnosed cardiopulmonary diseases (C group, n=10). The average age of the participants was 52.6(±5.9) years. Each exercise was performed for 3 min. During the exercises, heart rate (HR), oxygen consumption (VO2), blood lactate concentration (BLA), and rate of perceived exertion (RPE) were measured. In each pair of exercises, the latter part was more strenuous than the first. Walking in place was least and cross-country skiing the most strenuous mode of exercise. Energy expenditure (EE) ranged between 2.5±0…

medicine.medical_specialtybusiness.industryAquatic exercisePhysical Therapy Sports Therapy and RehabilitationCardiorespiratory fitnessPerceived exertionWalking in placeMetabolic equivalentEnergy expenditureHeart ratePhysical therapyMedicinebusinesshuman activitiesCardiopulmonary diseaseAdvances in Physiotherapy
researchProduct

Economic Evaluation Of Hospital Admissions For Patients With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtybusiness.industryEconomic evaluationmedicinePulmonary diseaseIntensive care medicinebusinessB47. COPD EXACERBATIONS: MISCELLANEOUS
researchProduct

High-Frequency Oscillatory Ventilation In Patients With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtybusiness.industryInternal medicineCardiologymedicinePulmonary diseaseIn patientbusinessHigh frequency oscillatory ventilationA48. CLINICAL RESEARCH
researchProduct

Efficacy Of Varenicline In Smokers With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtychemistry.chemical_compoundchemistrybusiness.industryInternal medicinemedicinePulmonary diseaseVareniclinebusinessB46. INHALED AND SYSTEMIC ANTI-INFLAMMATORY THERAPY IN COPD
researchProduct

Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD

2020

Poor performance in the 6-min walk test (6MWT &lt

medicine.medical_specialtylcsh:MedicinePulmonary diseaseLogistic regressionArticlemobility activities03 medical and health sciences0302 clinical medicineInternal medicine6MWTMedicineCOPDIn patient030212 general & internal medicinePrognostic modelsCOPDPerformance statusbusiness.industrylcsh:RGeneral Medicinemedicine.disease5STSpredictors030228 respiratory systemTest scorebusiness6 min walking testJournal of Clinical Medicine
researchProduct

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension deliver…

2018

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs), are central to the maintenance treatment of patients with COPD. Clinical studies have demonstrated that combined LAMA + LABA therapies improve efficacy while retaining a safety profile similar to LAMA or LABA alone. This has led to the development of several LAMA/LABA fixed-dose combination (FDC) therapies, which provide patients with the convenience of two active compounds in a single inhaler. GFF MDI (Bevespi Aerosphere®) is an FDC of glycopyrrolate/formote…

medicine.medical_specialtymedicine.drug_classDrug CompoundingFixed-dose combinationMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumans030212 general & internal medicineIntensive care medicineAdrenergic beta-2 Receptor AgonistsGlycopyrrolateCOPDbiologybusiness.industryInhalerGeneral MedicineLamamedicine.diseasebiology.organism_classificationGlycopyrrolateMetered-dose inhalerBronchodilator AgentsDrug CombinationsTreatment Outcome030228 respiratory systemFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Asthma-COPD overlap syndrome: recent advances in diagnostic criteria and prognostic significance.

2017

The term asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) has been proposed for individuals with features of both asthma and COPD. Several attempts have been done to define ACOS on the basis of medical history, symptoms, and functional findings. The main diagnostic criteria include airflow obstruction with a strong although incomplete reversibility to bronchodilation tests, a significant exposure to cigarette or biomass smoke, and a history of atopy or asthma. Additional diagnostic elements include eosinophilic airway and systemic inflammation, a good response to corticosteroid treatment, and a high concentration of exhaled nitric oxide. ACOS should be distinguish…

medicine.medical_specialtymedicine.drug_classPrognosiComorbidity030204 cardiovascular system & hematologySettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsInternal medicineBronchodilatorMedicineHumansMedical historyFunctional abilityAsthmaCOPDbusiness.industryRisk FactorMedicine (all)SmokingOverlap syndromeGeneral Medicinemedicine.diseasePrognosisComorbidityAsthmarespiratory tract diseases030228 respiratory systemExhaled nitric oxidebusinessHumanMinerva medica
researchProduct

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simula…

2020

Omar S Usmani,1 Nicola Scichilone,2 Benjamin Mignot,3 Dennis Belmans,3 Cedric Van Holsbeke,3 Jan De Backer,3 Roberta De Maria,4 Erika Cuoghi,4 Eva Topole,4 George Georges4 1Airway Disease Section, National Heart and Lung Institute, Imperial College, London, UK; 2PROMISE Department of Medicine, University of Palermo, Palermo, Italy; 3FLUIDDA, Kontich, Belgium; 4Chiesi Farmaceutici, SpA, Parma, ItalyCorrespondence: George GeorgesChiesi USA Inc., 175 Regency Woods Place, Ste. 600, Cary, NC 27518, USATel +1 (919) 678 6611 x1536Email george.georges@chiesi.comIntroduction: There is a clear correlation between small airways dysfunction and poor clinical outcomes in patients with chronic obstructiv…

medicine.medical_specialtymedicine.drug_classRespiratory SystemUrologyInternational Journal of Chronic Obstructive Pulmonary DiseaseSettore MED/10 - Malattie Dell'Apparato RespiratoriotomographyDry powder inhalers Inhaled corticosteroid Long-acting beta2 agonist Long-acting muscarinic antagonist Metered dose inhalers Tomography X-ray computedinhaled corticosteroidFluticasone propionatePulmonary Disease Chronic Obstructivechemistry.chemical_compoundFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumanslong-acting muscarinic antagonistComputer SimulationGlycopyrronium bromideRespiratory systemmetered dose inhalers1102 Cardiorespiratory Medicine and HaematologyOriginal Researchx-ray computedlcsh:RC705-779COPDScience & TechnologyInhalationbusiness.industrydry powder inhalersGeneral Medicinelcsh:Diseases of the respiratory systemrespiratory systemmedicine.diseaseBronchodilator AgentsDrug CombinationschemistryCorticosteroidVilanterolbusinessLife Sciences & Biomedicinelong-acting beta2 agonistmedicine.drugInternational Journal of COPD
researchProduct